Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC)
by on Thursday, July 19th, 2012 | No Comments
Condition: Hepatocellular Carcinoma
Interventions: Drug: Ulinastatin; Drug: Diammonium glycyrrhizinate
Sponsors: Eastern Hepatobiliary Surgery Hospital; Eastern Hepatobiliary Surgery Hospital
Recruiting – verified July 2012
Read the original post: Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC)